| Revision as of 00:05, 18 July 2017 edit172.85.51.6 (talk) →Career: Added separate section for Early life and education. Added information and links.← Previous edit | Revision as of 00:15, 18 July 2017 edit undo172.85.51.6 (talk)No edit summaryNext edit → | ||
| Line 19: | Line 19: | ||
| Puliafito participated in research into the use of ] for the treatment of retinal disorders.<ref name=michels/><ref name=rosenfeld/><ref name=rich/><ref name=mosh/> | Puliafito participated in research into the use of ] for the treatment of retinal disorders.<ref name=michels/><ref name=rosenfeld/><ref name=rich/><ref name=mosh/> | ||
| ==Awards== | |||
| Dr. Puliafito's honors and awards include the following:<ref name=Keck/> | |||
| * Boston Aid To The Blind Man of Vision, 1993 | |||
| * Leon Goldman Award, Biomedical Optics Society, 1993 | |||
| * The Richard and Hinda Rosenthal Award in the Visual Sciences, Macula Society, 1994 | |||
| * I Migliori Award of the Pirandello Lyceum of Massachusetts, 1994 | |||
| * Rank Prize in Opto-Electronics, 2002 | |||
| * ASCRS Innovator of the Year, Charles D. Kelman Innovator’s Lecture, Washington DC, April 19, 2005 | |||
| * Shaler Richardson, MD, Service to Medicine Award, Florida Society of Ophthalmology, 2005 | |||
| * Scientist of the Year, Hope for Vision, 2006 | |||
| * The Bascom H. Palmer Community Service Award, Miami Lighthouse for the Blind 2006 | |||
| * ], of the University at Buffalo, 2006 | |||
| * J. Donald M. Gass Award of the Macula Society, 2008 | |||
| * ] Secretariat Award, June 2008 | |||
| * ], ARVO Fellow, May 2009 | |||
| * Marquis Who’s Who in America, 2008, 2009, 2010 | |||
| * Who’s Who in Medicine and Healthcare 2009-2010 | |||
| * ] Life Achievement Honor Award, August 2010 | |||
| * National Hispanic Health Foundation Leadership Award, 2011 | |||
| * ] Vision Award, 2012 | |||
| * Los Angeles County Medical Association Innovation Award for Technology, 2013 | |||
| * Pasadena Magazine Top Doctors in Ophthalmology, 2014 | |||
| == Controversy == | == Controversy == | ||
| Line 39: | Line 62: | ||
| ] | ] | ||
| ] | ] | ||
| ] | |||
| ] | ] | ||
| ] | |||
| ] | ] | ||
| ] | ] | ||
Revision as of 00:15, 18 July 2017
 |
Carmen A. Puliafito is an American ophthalmologist and former dean of the University of Southern California medical school, the Keck School of Medicine.
Early life and education
Puliafito was born in Buffalo, New York. He is a 1973 graduate of Harvard College and graduated magna cum laude in 1979 from Harvard Medical School. Dr. Puliafito trained in ophthalmology at Massachusetts Eye and Ear Infirmary, completing an ophthalmology residency in 1982 and a fellowship in vitreoretinal surgery in 1984. Additionally, he completed an MBA from the Wharton School of the University of Pennsylvania in 1997.
Career
Dr. Puliafito's career in ophthalmology began at Massachusetts Eye and Ear Infirmary, where he founded the Laser Research Laboratory and directed the Morse Laser Center. Dr. Puliafito was chair of the Department of Ophthalmology at Tufts University School of Medicine from 1991 to 2001. From 2001 to 2007 he was director of the Bascom Palmer Eye Institute of the University of Miami Miller School of Medicine, and chair of the department of ophthalmology. Puliafito was appointed dean of USC's Keck school in December 2007. In 2012 he was 21st of the most highly-paid research university executives in the United States. In March 2016, Puliafito resigned as dean and USC professor Rohit Varma was appointed interim dean.
He has served on the board of the Children's Hospital Los Angeles.
Research
Puliafito was one of the inventors of optical coherence tomography (OCT); for this work, James Fujimoto, Eric Swanson and Puliafito received a Rank Prize for Opto-electronics in 2002. In 2012 Fujimoto, Swanson and David Huang, with Puliafito and Joel Schuman, received an António Champalimaud Vision Award from the Champalimaud Foundation.
Puliafito participated in research into the use of bevacizumab for the treatment of retinal disorders.
Awards
Dr. Puliafito's honors and awards include the following:
- Boston Aid To The Blind Man of Vision, 1993
- Leon Goldman Award, Biomedical Optics Society, 1993
- The Richard and Hinda Rosenthal Award in the Visual Sciences, Macula Society, 1994
- I Migliori Award of the Pirandello Lyceum of Massachusetts, 1994
- Rank Prize in Opto-Electronics, 2002
- ASCRS Innovator of the Year, Charles D. Kelman Innovator’s Lecture, Washington DC, April 19, 2005
- Shaler Richardson, MD, Service to Medicine Award, Florida Society of Ophthalmology, 2005
- Scientist of the Year, Hope for Vision, 2006
- The Bascom H. Palmer Community Service Award, Miami Lighthouse for the Blind 2006
- Lucien Howe Medal, of the University at Buffalo, 2006
- J. Donald M. Gass Award of the Macula Society, 2008
- American Academy of Ophthalmology Secretariat Award, June 2008
- Association for Research in Vision and Ophthalmology, ARVO Fellow, May 2009
- Marquis Who’s Who in America, 2008, 2009, 2010
- Who’s Who in Medicine and Healthcare 2009-2010
- American Academy of Ophthalmology Life Achievement Honor Award, August 2010
- National Hispanic Health Foundation Leadership Award, 2011
- António Champalimaud Vision Award, 2012
- Los Angeles County Medical Association Innovation Award for Technology, 2013
- Pasadena Magazine Top Doctors in Ophthalmology, 2014
Controversy
The Los Angeles Times reported in a July 17, 2017 expose that while Pulafito served as dean and USC professor, he "kept company with a circle of criminals and drug users who said he used methamphetamine and other drugs with them." Three weeks before resigning as dean, a 21-year-old prostitute (as reported by the Los Angeles Times) had overdosed in his presence in a Pasadena hotel room. The LA Times reported that police found methamphetamine in the hotel room.
References
- ^ "Carmen A. Puliafito, MD, MBA". eye.keckmedicine.org.
- "Carmen A. Puliafito, MD, MBA, Former Dean of Keck School of Medicine of the University of Southern California, Joins Ophthotech as Chief of Strategic Development". Business Wire. April 28, 2016. Retrieved 17 July 2017.
- ^ Carmen Puliafito named new dean of the Keck School of Medicine. University of Southern California. Accessed February 2015.
- "About Carmen A. Puliafito". Retrieved 17 July 2017.
- USC Press Release. Dec 5 2007. USC Installs Dr. Carmen Puliafito as New Dean of the Keck School of Medicine
- Alex Philippidis (Nov 18, 2013). "25 Top-Paid Research University Leaders". Genetic Engineering & Biotechnology News. Accessed February 2015.
- Maamoon, Noorhan. "Dean of Keck School of Medicine of USC resigns". Daily Trojan. Retrieved 2016-04-03.
- http://www.chla.org/site/c.ipINKTOAJsG/b.5264283/
- ^ (May 2002). New Products. Optometry & Vision Science 79 (5): 279–280. Accessed February 2015.
- 2012: Williams & Fujimoto, Huang, Puliafito, Schuman, Swanson. Champalimaud Foundation. Accessed February 2015.
- Michels S, Rosenfeld PJ, Puliafito CA, Marcus EN, Venkatraman AS. (2005). Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration twelve-week results of an uncontrolled open-label clinical study. Ophthalmology 112:1035–47.
- Rosenfeld PJ, Moshfegi AA, Puliafito CA. (2005). Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmic Surgery, Lasers & Imaging 36: 331–5.
- Rich RM, Rosenfeld PJ, Puliafito CA, et al. (2006). Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Retina 26: 495–511.
- Moshfegi AA, Rosenfeld PJ, Puliafito CA, et al. (2006). Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration: twenty-four-week results of an uncontrolled open-label clinical study. Ophthalmology 113: 2002–11.
- ^ "An overdose, a young companion, drug-fueled parties: The secret life of USC med school dean". Los Angeles Times. ISSN 0458-3035. Retrieved 2017-07-17.